Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-10-24

FDA Approved: CAMRESE LO — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Camrese Lo under an original application; it is a combined oral contraceptive containing levonorgestrel and ethinyl estradiol.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Camrese Lo (LEVONORGESTREL/ETHINYL ESTRADIOL)

Snippet

ORIG AP for CAMRESE LO (LEVONORGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL)